1-5 of 5
Matthew Bye
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Early Outcomes of Second-Line Axicabtagene Ciloleucel (Axi-Cel) Therapy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Dasom (Caroline) Lee, Swetha Kambhampati, Maria Silvina Odstrcil Bobillo, Babatunde Adedokun, Mazyar Shadman, Amanda L. Olson, Alex F. Herrera, Catherine J. Lee, Caron A. Jacobson, Matthew Bye, Mehdi Hamadani, Soyoung Kim, Saurabh Dahiya, Zhen-Huan Hu, Kelly Speth, Christina To, Debbie L. Mirjah, Timothy Best, Frederick L. Locke, Nausheen Ahmed, Michael T. Tees, Marcelo C. Pasquini, Sairah Ahmed
Journal: Blood
Blood (2024) 144 (Supplement 1): 526.
https://doi.org/10.1182/blood-2024-199139
Published: 2024
Journal Articles

Single-Agent Ibrutinib Versus Allogeneic Hematopoietic Cell Transplantation for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and del(17p)

Farrukh T. Awan, Ran Liu, Hsin-Hui Huang, Matthew Bye, Kwang Wooahn, Gabriel S. Krigsfeld, Anat Raz, Heather R Wolfe, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 2178.
https://doi.org/10.1182/blood-2024-194156
Published: 2024
Journal Articles

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Kitsada Wudhikarn, Evandro Bezerra, Yang Yang, Miguel-Angel Perales, Nitin Jain, Usama Gergis, Ahmed Aribi, LaQuisa Hill, Jessica T. Leonard, Forat Lutfi, Soyoung Kim, Matthew Bye, Zhen-Huan Hu, Hai-Lin Wang, Zhong-Cheng Luo, Rubina Siddiqi, Rita Damico Khalid, Jessica Speiser, Marcelo C. Pasquini, Partow Kebriaei, Lori Muffly
Journal: Blood
Blood (2024) 144 (Supplement 1): 5092.
https://doi.org/10.1182/blood-2024-198455
Published: 2024
Journal Articles

Real World Comparison of Efficacy and Safety of Fludarabine-Versus Bendamustine-Based Lymphodepleting Chemotherapy for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Relapse/Refractory (r/r) Large B-Cell Lymphoma (LBCL)

Alaa Ali, Nausheen Ahmed, Soyoung Kim, Matthew Bye, Sayeef Mirza, Alex Gordon Sieg, Christopher Strouse, Kalyan Nadiminti, Priyanka A. Pophali, Rammurti T. Kamble, Lohith Gowda, Cameron J. Turtle, Christine L. Phillips, Marcelo C. Pasquini, Sairah Ahmed, Siddhartha Ganguly, Amy Moskop
Journal: Blood
Blood (2024) 144 (Supplement 1): 71.
https://doi.org/10.1182/blood-2024-200269
Published: 2024
Journal Articles

Real-World Outcomes of Brexucabtagene Autoleucel (brexu-cel) for Relapsed or Refractory (R/R) Adult B-Cell Acute Lymphoblastic Leukemia (B-cell ALL): Evidence from the CIBMTR Registry

Evandro Bezerra, Taha Itani, Kistada Wudhikarn, Miguel-Angel Perales, Yang Yang, Usama Gergis, Ahmed Aribi, LaQuisa C. Hill, Nitin Jain, Jessica T. Leonard, Forat Lutfi, Soyoung Kim, Matthew Bye, Hai-Lin Wang, Tsveta Hadjivassileva, Liana Nikolaenko, Ioana Kloos, Amina Abdeldaim, David Dalton, Hairong Xu, Marcelo Pasquini, Partow Kebriaei
Journal: Blood
Blood (2023) 142 (Supplement 1): 1029.
https://doi.org/10.1182/blood-2023-177693
Published: 2023